Each year I make a list of stem cell predictions for the following year and I’ll release my predictions for 2019 soon, but first I’m grading how my 20 predictions for 2018 turned out. It seems I did better than usual predicting what would happen this year. I only got a couple partial credit or […]
Good final grades on my 20 x 2018 stem cell predictions Read More »
The FDA has issued a recall of the main stem cell product of a California firm called Liveyon that is linked to unproven stem cell clinics. The recall seems to have been due to “adverse reactions.” An emerging big player in the birth-related stem cell clinic area? I’ve been hearing the name Liveyon pop up
FDA recalls Liveyon stem cell product: blow to big clinic supplier? Read More »
Here is my initial list of 2019 Stem Cell Meetings & Conferences. Send me your listings if you don’t see your meeting here so I can start fleshing out the list more. Meeting listings are not endorsements and I try to make this list fairly comprehensive of as many stem cell meetings as I can.
A germinal list of 2019 stem cell meetings and conferences Read More »
Here is our listing of 2019 Stem Cell Meetings & Conferences. Send me your listings if you don’t see your meeting here. Meeting listings are not endorsements and I try to make this list fairly comprehensive. January ARM Cell & Gene Therapies State of the Industry Briefing San Francisco, CA, USA (Held January 7, 2019)
2019 Stem Cell Meetings List Read More »
We heard this week about the encouraging news of a new CRISPR-stem cell collaboration between stem cell biotech ViaCyte and CRISPR Therapeutics. The goal of the team is to make genetically engineered pancreatic derivatives from stem cells that would have a unique immune stealthiness. If such an approach was successful, patients would not need to
Quick Q&A with ViaCyte CEO on CRISPR-stem cell work Read More »
Stem cell news is always burbling up, sometimes right there in front of us on the web and other times via networks of people. Astellas news. Some may remember there used to be this pioneering stem cell biotech called ACT, which then became Ocata, and finally was acquired by the big company Astellas. One of
Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers Read More »
The year of 2018 has already been a wild one for stem cell news. There are many developments on a variety of fronts. Here are some of the most notable news bites of the last month or so. RMATs RMAT Wave. The FDA continues its warp-speed issuance of Regenerative Medicine Advanced Therapy (RMAT) designations with
Stem cell news July 2018: RMATs, RTT, MiMedx mess, clinic family ties & more Read More »
Every year in December I go out onto a limb and make stem cell predictions for the coming year as I did in late 2017 for this year. Then usually around the 1/2-way point through the year I check in on how the predictions are faring so far at that point. In this post I give
Midterm grades on my 20 x 2018 stem cell predictions Read More »
Periodically I also try to post (as I am today) specifically about stem cell good news amongst all the swirling developments out there. You can see the most recent past installment focused on good news here that include vascularized organoids. I recently stumbled on this quote that for me linked up the potential of stem cells
3 bits of stem cell good news Read More »
Is “snake oil” too harsh a term for some of what is sold at some of the worst stem cell clinics? Is the phrase “stem cell clinics” itself accurate and useful in a broad sense? When we read or write the phrase “stem cell clinics”, most people generally know what we’re talking about, but it
What should we call “stem cell clinics” & is “snake oil” too harsh for some? Read More »